YO

YourChoice

7 known investors

yourchoicetx.com ↗

YourChoice Therapeutics is developing YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials. The company targets male contraceptive users seeking alternatives to condoms or vasectomy.

Founders & leadership

AB

Akash Bakshi, MScCo-founder & CEO

NM

Nadja Mannowetz, PhDCo-founder & CSO

Investors · 7

BL

Blue Bear VenturesSan Francisco · $100K – $400K

CI

Civilization Ventures Management, LlcTiburon · $1M – $10M

FO

Foreground CapitalBoston

FU

Future VenturesLos Altos · $1M – $10M

PO

PortfoliaSan Mateo

OL

Olive Tree CapitalreportedBoston

RE

Refactor CapitalreportedBurlingame · $1M – $2M